Literature DB >> 11165096

A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development.

V K Gupta1, T E Beckert, J C Price.   

Abstract

A novel delivery system was developed for delivering drugs to the colon by selecting polymethacrylates with appropriate pH dissolution characteristics for the distal end of the small intestine and relying upon the relatively constant transit time of the small intestine. Pellets were prepared by powder layering of 5-aminosalicylic acid (5-ASA) on nonpareils (0.5-0.6 mm) in a conventional coating pan. Drug-layered pellets were coated with an inner layer of a combination of two pH-independent polymers Eudragit RL and RS (2:8), and an outer layer of a pH-dependent polymer, Eudragit FS. Scanning electron micrograph (SEM) pictures of the coated pellets showed the uniformity of both the coatings. The release profile of 5-ASA was studied in three phosphate buffers after a simulated gastric pre-soak for 2 h in pH 1.2 media. There was no drug release for 12 h at pH 6.5. There was a sustained release of 5-ASA for over 12 h both at pH 7.0 and 7.5 after a lag time at pH 7.0 and no lag time at pH 7.5. The release rate was faster at pH 7.5 than at pH 7.0. The delivery system demonstrated its potential for colonic delivery by resisting drug release until pH 6.5 and the combination of Eudragit RL and RS proved successful for the sustained delivery of 5-ASA at the expected pH of the colon.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165096     DOI: 10.1016/s0378-5173(00)00649-9

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates.

Authors:  Mei-Juan Zou; Gang Cheng; Hirokazu Okamoto; Xiu-Hua Hao; Feng An; Fu-De Cui; Kazumi Danjo
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

2.  Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography.

Authors:  Puja Sharma; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2013-04-25       Impact factor: 3.246

3.  Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.

Authors:  Yi-Nuo Pang; Yan Zhang; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 4.  Advances in colonic drug delivery.

Authors:  Abdul W Basit
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Dry powder coating of pellets with micronized Eudragit RS for extended drug release.

Authors:  Nantharat Pearnchob; Roland Bodmeier
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

6.  Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin.

Authors:  Jitendra R Amrutkar; Surendra G Gattani
Journal:  AAPS PharmSciTech       Date:  2009-05-21       Impact factor: 3.246

7.  The mechanisms of 5-FU-PLA-O-CMC-NPS-mediated inhibition of the proliferation of colorectal cancer cell line SW480.

Authors:  Jing Wu; Le Zhang; Guo-dong Yang; Xiang-chun Lin; Rui Ji; Cang-hai Wang; Wen-jing Lou; Xiao-bo Wang
Journal:  Tumour Biol       Date:  2014-04-17

8.  Colon Targeting of Naringin for Enhanced Cytoprotection Against Indomethacin-Induced Colitis in Rabbits.

Authors:  Eman Ebrahim El Naggar; Elham Abdelmonem Mohamed; Thanaa Mohamed Borg; Ahmed Ramadan El-Sheakh; Mohammed Fawzy Hamed
Journal:  Drug Des Devel Ther       Date:  2020-02-19       Impact factor: 4.162

9.  Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis via scintigraphy.

Authors:  Pooja Mongia Raj; Rakesh Raj; Ankur Kaul; Anil K Mishra; Alpana Ram
Journal:  RSC Adv       Date:  2018-06-06       Impact factor: 4.036

10.  Kinetic characterization of Vibrio cholerae ApbE: Substrate specificity and regulatory mechanisms.

Authors:  Xuan Fang; Pingdong Liang; Daniel Alexander Raba; Mónica Rosas-Lemus; Srinivas Chakravarthy; Karina Tuz; Oscar Juárez
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.